AnHeart Therapeutics

欢迎收听本期的中国生物制药热点话题直播间，我是主持人Brian Yang。 今天我和Dexter Yan以及特邀嘉宾，Citeline在英国的编辑Andrew Cognahie一起，为大家带来两个话题的讨论。 第一个话题，是最近刚刚在圣地亚哥召开的AACR年会。 每年的年会，都是抗肿瘤药企争相发布最新的临床数据的机会。 这次年后上，中国公司带来哪些亮点？Dexter最近写了AACR的专题报道，我请

The potential impact of the proposed US BIOSECURE Act continues to spread as the Biden administration increases its focus on China. But with BIO's top lobbyist and the top House sponsor of the legisla

Serial biopharma entrepreneur David Hung’s Nuvation Bio had been struggling to inspire investors, but a buyout of AnHeart Therapeutics has transformed its prospects overnight. The all-share deal i

Big backing for venture capital-funded private biopharmaceutical companies has not wavered as 2021 draws to a close despite a recent slowdown in large initial public offerings by drug developers in th